NCT00299377View on ClinicalTrials.gov

Abciximab i.v. Versus i.c. in Primary PCI Patients With STEMI

PHASE2/PHASE3CompletedINTERVENTIONAL
Enrollment

150

Participants

Timeline

Start Date

January 31, 2006

Primary Completion Date

November 30, 2007

Study Completion Date

February 29, 2008

Conditions
Myocardial Infarction
Interventions
DRUG

Abciximab i.v.

DRUG

Abciximab i.c.

Trial Locations (1)

04289

University of Leipzig - Heart Center, Leipzig

All Listed Sponsors
lead

University of Leipzig

OTHER

NCT00299377 - Abciximab i.v. Versus i.c. in Primary PCI Patients With STEMI | Biotech Hunter | Biotech Hunter